Document is current
Any future updates will be listed below
-
Authors
Thiyagarajah, Mathura T.
Herrmann, Nathan
Ruthirakuhan, Myuri
Li, Abby
Lanctôt, Krista L.
-
Funding
Funding for this research was provided by:
Alzheimer's Drug Discovery Foundation (N/A)
Alzheimer Society of Canada (N/A, 15–17)
National Institute of Health (N/A)
Canadian Institutes of Health Research (N/A)
Axovant, Lundbeck, and Roche (N/A)
Canadian Institutes of Health Research Doctoral Research Award (N/A)
National Institute of Aging (R01AG046543)
Alzheimer’s Drug Discovery Foundation (20140503)
- License Information
-
More Information
Article History
First Online: 2 July 2019
Compliance with Ethical Standards
:
: Nathan Herrmann has received research grants from the Alzheimer Drug Discovery Foundation, the Alzheimer Society of Canada, the National Institute of Health, Canadian Institutes of Health Research, Axovant, Lundbeck, and Roche and consultation fees from Lilly, Merck, Pfizer, and Astellas. Myuri Ruthirakuhan was funded by a Canadian Institutes of Health Research Doctoral Research Award. Krista L. Lanctôt has received research grants from the National Institute of Aging (R01AG046543), Alzheimer’s Drug Discovery Foundation (grant no. 20140503)/Cures Within Reach, the Alzheimer Society of Canada (Grant 15–17), Alzheimer’s Association (grant no. PTC-18-543,823), Canadian Institutes of Health Research (grant no. MOP201610PJT) and honoraria from AbbVie, Abide Therapeutics, and Lundbeck/Otsuka. Mathura Thiyagarajah and Abby Li have no conflicts to declare.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
